Guido Barosco*, Roberta Morbio, Francesca Chemello, Roberto Tosi and Giorgio Marchini
This short review evaluates how the therapeutic interventions for Coronavirus Disease-19 (COVID-19) could lead to the development of an Acute Primary Angle Closure (APAC) and Primary Angle Closure Glaucoma (PACG). The 2 recent reports share some important features related to the settings of the pathological ophthalmic conditions. Patients’ severe clinical conditions and prolonged systemic therapies could mask their symptoms and delay the diagnosis. Recognition of early signs of Primary Angle Closure (PAC) is crucial to averting its progression to PACG. It is therefore necessary to warn anesthesiologists and intensivist doctors to be aware of the ophthalmic risks of the general therapy against the COVID-19 in the Intensive Care Unit (ICU) in order to promptly detect signs and symptoms on an Acute Primary Angle Closure (APAC).
